Status:
UNKNOWN
Study on the Effectiveness of AF Analysis Software in AF Rhythm Monitoring
Lead Sponsor:
Beijing Anzhen Hospital
Collaborating Sponsors:
Heart Health Research Center
Conditions:
Atrial Fibrillation
Atrial Fibrillation Paroxysmal
Eligibility:
All Genders
18-80 years
Brief Summary
Atrial fibrillation (AF) is a serious public health problem because of its increasing incidence and prevalence in the aging population. ECG is the most commonly used gold standard for clinical diagnos...
Detailed Description
PPG-AF study is a Cohort randomized observational study.The trial will include patients with AF who meet the study requirements from Beijing Anzhen Hospital within 2 months. Each participant will wear...
Eligibility Criteria
Inclusion
- Be at least 18 years of age.
- Have clear ECG-recorded atrial fibrillation in the past and will undergo atrial fibrillation ablation in the current hospitalization.
- Patients who agree to wear both the watch and the ECG recorder.
Exclusion
- Inability to wear the watch due to limited mobility or other problems.
- Severe skin diseases such as skin allergies or skin ulcers.
- Chronic insomnia not treated with medication.
- Patients with severe cardiovascular disease who may be resuscitated at any time.
- Previous history of Parkinson's, schizophrenia, epilepsy.
- Black people and those with excessively dark skin.
Key Trial Info
Start Date :
August 29 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT05333380
Start Date
August 29 2022
End Date
July 1 2023
Last Update
October 14 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China
2
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China